Renin-angiotensin inhibitor use was lower in those with CKD ( eGFR < 60 ml/min per 1.73 m ( 2 ) ) ( 58 % versus 68 % ; P = 0.004 ) and higher in individuals with diabetes ( 41 % versus 27 % ; P < 0.001 ) .